| C08CA01 |
Amlodipine |
NORVASC |
Tablet |
5 |
mg |
30 |
Pfizer Europe MA EEIG, Белгия |
5 |
mg |
- |
5.66 |
0.02683 |
0.8 |
50% |
0.4 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9,I25.5 |
НСР-2340/13.01.2014; НСР-5941/01.04.2015.; НСР-10373/26.09.2016; НСР-17200/09.11.2018 |
02.12.2018 |
08.09.2012 |
|
Активен |
3718 |
| C08CA01 |
Amlodipine |
TENOX |
Tablet |
5 |
mg |
90 |
KRKA, d.d., Словения |
5 |
mg |
- |
13.94 |
0.05367 |
4.83 |
50% |
2.42 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9,I25.5 |
№ 70/ 19.04.2010; НСР-3566/23.05.2014 |
16.06.2014 |
08.09.2012 |
|
Заличен |
901 |
| C08CA01 |
Amlodipine |
TENOX |
Tablet |
5 |
mg |
30 |
KRKA, d.d., Словения |
5 |
mg |
- |
3.02 |
0.02683 |
0.8 |
50% |
0.4 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9,I25.5 |
КЦРР-467/19.04.2012 г.; НСР-557/23.07.2013 |
16.03.2015 |
08.09.2012 |
|
Активен |
2023 |
| C08CA01 |
Amlodipine |
TENOX |
Tablet |
10 |
mg |
30 |
KRKA, d.d., Словения |
5 |
mg |
- |
3.84 |
0.02683 |
1.61 |
50% |
0.8 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9,I25.5 |
КЦРР-467/19.04.2012 г.; НСР-6611/01.07.2015; HCP-10162/31.08.2016 |
02.10.2016 |
08.09.2012 |
|
Активен |
1183 |
| C08CA01 |
Amlodipine |
Vasodipin |
Tablet |
10 |
mg |
30 |
Софарма АД, България |
5 |
mg |
- |
3.23 |
0.05367 |
3.22 |
50% |
1.61 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9,I25.5 |
КЦРР-1604/05.11.2012 г.; НСР-2037/11.12.2013 |
16.01.2014 |
|
|
Заличен |
1437 |
| C08CA01 |
Amlodipine |
Vasodipin |
Tablet |
5 |
mg |
30 |
Софарма АД, България |
5 |
mg |
- |
1.61 |
0.05367 |
1.61 |
50% |
0.81 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9,I25.5 |
КЦРР-1604/05.11.2012 г; НСР-2036/11.12.2013 |
16.01.2014 |
|
|
Заличен |
1436 |
| C08CA02 |
Felodipine |
C08CA02 Felodipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA02 |
Felodipine |
AURONAL |
Prolonged release tablet |
2.5 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
5 |
mg |
- |
6.58 |
0.07533 |
1.13 |
50% |
0.56 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-15640/10.05.2018 |
02.06.2018 |
08.09.2012 |
|
Активен |
415 |
| C08CA02 |
Felodipine |
AURONAL |
Prolonged release tablet |
5 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
5 |
mg |
- |
7.21 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-15639/10.05.2018 |
02.06.2018 |
08.09.2012 |
|
Активен |
416 |
| C08CA02 |
Felodipine |
AURONAL |
Prolonged release tablet |
10 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
5 |
mg |
- |
11.41 |
0.07533 |
4.52 |
50% |
2.26 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-15638/10.05.2018 |
02.06.2018 |
08.09.2012 |
|
Активен |
414 |
| C08CA02 |
Felodipine |
Felicipin |
Prolonged release tablet |
5 |
mg |
30 |
Актавис EАД, България |
5 |
mg |
- |
8.46 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-16036/29.06.2018 |
02.08.2018 |
08.09.2012 |
|
Заличен |
208 |
| C08CA02 |
Felodipine |
Felodipine-Ratiopharm |
Prolonged release tablet |
5 |
mg |
30 |
Ratiopharm GmbH, Германия |
5 |
mg |
- |
6.3 |
0.21 |
6.3 |
50% |
3.15 |
|
I10,I11,I12,I13,I20 |
№25/03.08.2009; ; КЦРР-1847/12.12.2012 г; КЦРР-2935/20.03.2013 |
26.04.2013 |
08.09.2012 |
|
Заличен |
1571 |
| C08CA02 |
Felodipine |
Felodipine-Ratiopharm |
Prolonged release tablet |
10 |
mg |
30 |
Ratiopharm GmbH, Германия |
5 |
mg |
- |
13.12 |
0.21867 |
13.12 |
50% |
6.56 |
|
I10,I11,I12,I13,I20 |
№25/03.08.2009; ; КЦРР-1847/12.12.2012 г; КЦРР-2931/20.03.2013 |
26.04.2013 |
08.09.2012 |
|
Заличен |
1572 |
| C08CA02 |
Felodipine |
FELODIPINE-TCHAIKAPHARMA |
Prolonged release tablet |
5 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
5 |
mg |
- |
4.52 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
№ 66/ 08.04.2010; № 84/27.05.2010; НСР-16802/20.09.2018 |
02.11.2018 |
08.09.2012 |
|
Активен |
764 |
| C08CA02 |
Felodipine |
FeloHEXAL |
Prolonged release tablet |
5 |
mg |
30 |
Hexal AG, Германия |
5 |
mg |
- |
5.04 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-1285/21.08.2012 г.; НСР-7486/12.11.2015; КП-37/04.04.2019 и НСР-17890/07.02.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
1361 |
| C08CA02 |
Felodipine |
FeloHEXAL |
Prolonged release tablet |
10 |
mg |
30 |
Hexal AG, Германия |
5 |
mg |
- |
4.52 |
0.07533 |
4.52 |
50% |
2.26 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КП-201/30.04.2015 и НСР-1817/25.11.2013 |
02.06.2015 |
08.09.2012 |
|
Активен |
3884 |
| C08CA02 |
Felodipine |
Plendil |
Prolonged release tablet |
5 |
mg |
30 |
Astra Zeneca AB, Швеция |
5 |
mg |
- |
11.1 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-491/19.04.2012 г.; НСР-3974/30.06.2014.; НСР-7514/19.11.2015.; НСР-12385/18.04.2017 |
02.06.2017 |
08.09.2012 |
|
Активен |
2996 |
| C08CA02 |
Felodipine |
PRESID 10 MG |
Prolonged release tablet |
10 |
mg |
30 |
Teva B.V., Нидерландия |
5 |
mg |
- |
11.06 |
0.07533 |
4.52 |
50% |
2.26 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-740/07.06.2012 г.; КЦРР-2837/20.03.2013 г.; НСР-3700/06.06.2014; НСР-16259/27.07.2018; НСР-17184/09.11.2018 |
02.12.2018 |
08.09.2012 |
|
Активен |
2913 |
| C08CA02 |
Felodipine |
PRESID 2,5 MG |
Prolonged release tablet |
2.5 |
mg |
30 |
Teva B.V., Нидерландия |
5 |
mg |
- |
2.87 |
0.07533 |
1.13 |
50% |
0.57 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-740/07.06.2012 г.; КЦРР-2844/20.03.2013 г; НСР-2299/13.01.2014; НСР-4671/25.09.2014; НСР-17175/09.11.2018 |
02.12.2018 |
08.09.2012 |
|
Активен |
2464 |
| C08CA02 |
Felodipine |
PRESID 5 MG |
Prolonged release tablet |
5 |
mg |
30 |
Teva B.V., Нидерландия |
5 |
mg |
- |
5.93 |
0.07533 |
2.26 |
50% |
1.13 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
КЦРР-740/07.06.2012 г.; КЦРР-2838/20.03.2013 г.; НСР-3700/06.06.2014.; НСР-6785/23.07.2015.; НСР-16769/07.09.2018 |
02.10.2018 |
08.09.2012 |
|
Активен |
2912 |
| C08CA05 |
Nifedipine |
C08CA05 Nifedipine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08CA05 |
Nifedipine |
Adalat Eins 30 |
Prolonged release tablet |
30 |
mg |
30 |
Bayer Pharma AG, Германия |
30 |
mg |
- |
14.54 |
0.12325 |
3.7 |
50% |
1.85 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-138/07.06.2013; НСР-2930/07.03.2014; НСР-7339/29.10.2015 |
02.12.2015 |
08.09.2012 |
|
Заличен |
1888 |
| C08CA05 |
Nifedipine |
Adalat Oros 30 |
Prolonged release tablet |
30 |
mg |
28 |
Bayer HealthCare AG,, Германия |
30 |
mg |
- |
21.59 |
0.13025 |
3.65 |
50% |
1.82 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-5560/29.01.2015 |
16.02.2015 |
08.09.2012 |
|
Заличен |
359 |
| C08CA05 |
Nifedipine |
Cordaflex |
Prolonged release tablet |
20 |
mg |
60 |
EGIS Pharmaceuticals PLC, Унгария |
30 |
mg |
- |
4.86 |
0.1215 |
4.86 |
50% |
2.43 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
НСР-3551/16.05.2014; КП-29/05.03.2015 и НСР-1520/25.10.2013; НСР-13080/29.06.2017 |
02.08.2017 |
08.09.2012 |
|
Активен |
3646 |
| C08CA05 |
Nifedipine |
Cordaflex |
Prolonged release tablet |
20 |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
30 |
mg |
- |
3.74 |
0.1215 |
2.43 |
50% |
1.21 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.1,I20.8,I20.9 |
|
02.08.2017 |
08.09.2012 |
|
Активен |
370 |